Statement on hydroxychloroquine: COVID-19 Clinical Pharmacology Task Group - Canada.ca
Description
The ad-hoc Clinical Pharmacology Task Group recommends against the use of hydroxychloroquine as a treatment for patients with COVID-19 due to negligible evidence of efficacy and significant potential for harm.